These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 4407865)
1. Atypical mycobacteriosis of the urinary tract. A case report of extensive disease caused by the Battey bacillus. Pergament M; Gonzalez R; Fraley EE JAMA; 1974 Aug; 229(7):816-7. PubMed ID: 4407865 [No Abstract] [Full Text] [Related]
2. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments]. Janowiec M; Andrzejczyk Z; Szwedowicz I Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945 [No Abstract] [Full Text] [Related]
3. A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971. Abbott MR Med J Aust; 1973 Jun; 1(23):1144-6. PubMed ID: 4199110 [No Abstract] [Full Text] [Related]
4. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics]. Golyshevskaia VI; El'shanskaia MP Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666 [No Abstract] [Full Text] [Related]
5. Mycobacteria fortuitum in the urinary tract: a case report. Rosen DI J Urol; 1975 Dec; 114(6):951-2. PubMed ID: 1195483 [No Abstract] [Full Text] [Related]
7. Mycobacterium fortuitum infections: a review with two illustrative cases. Halpern AA; Nagel DA Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293 [TBL] [Abstract][Full Text] [Related]
8. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)]. Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477 [TBL] [Abstract][Full Text] [Related]
9. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya. Elghoul MT; Joshi RM; Rizghalla T Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554 [TBL] [Abstract][Full Text] [Related]
10. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results]. Tsukamura M; Yamori S Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003 [TBL] [Abstract][Full Text] [Related]
11. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis. Ogawa T; Motomura K Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006 [No Abstract] [Full Text] [Related]
12. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report. Elston HR; Duffy JP Am Rev Respir Dis; 1973 Oct; 108(4):944-9. PubMed ID: 4582438 [No Abstract] [Full Text] [Related]
13. Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case. Jenkin DJ; Dall G J Bone Joint Surg Br; 1975 Aug; 57(3):373-5. PubMed ID: 1158950 [TBL] [Abstract][Full Text] [Related]
14. Rationale for chemotherapy of tuberculosis and current recommendations. Kumar L Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486 [No Abstract] [Full Text] [Related]
15. Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis. Gacad G; Massaro D Am Rev Respir Dis; 1974 Feb; 109(2):274-8. PubMed ID: 4811782 [No Abstract] [Full Text] [Related]
16. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii. Harris GD; Johnason WG; Nicholson D Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296 [No Abstract] [Full Text] [Related]
17. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. Dickinson JM; Aber VR; Mitchison DA Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404 [TBL] [Abstract][Full Text] [Related]
18. [Culture and susceptibility testing of mycobacteria with VersaTREK]. Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229 [TBL] [Abstract][Full Text] [Related]